Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial.

Bojang, K A; Milligan, P J; Pinder, M; Vigneron, L; Alloueche, A; Kester, K E; Ballou, W R; Conway, D J; Reece, W H; Gothard, P; Yamuah, L; Delchambre, M; Voss, G; Greenwood, B M; Hill, A; McAdam, K P; Tornieporth, N; Cohen, J D; Doherty, T

Bojang, K A; Milligan, P J; Pinder, M; Vigneron, L; Alloueche, A; Kester, K E; Ballou, W R; Conway, D J; Reece, W H; Gothard, P; Yamuah, L; Delchambre, M; Voss, G; Greenwood, B M; Hill, A; McAdam, K P; Tornieporth, N; Cohen, J D; Doherty, T.

Affiliation

Bojang KA; Medical Research Council Laboratories, PO Box 273, The, Banjul, Gambia. kbojang@mrc.gm

Lancet ; 358(9297): 1927-34, 2001 Dec 08.

Article in En | MEDLINE | ID: mdl-11747915

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Plasmodium falciparum / Recombinant Proteins / Vaccines, Synthetic / Malaria, Falciparum / Malaria Vaccines Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Animals / Humans / Male Country/Region as subject: Africa Language: En Journal: Lancet Year: 2001 Document type: Article Affiliation country: Gambia Country of publication: Reino Unido

Search on Google

Add to My VHL

XML

PubMed Links